ロード中...
Combined Treatment with Doxorubicin and Rapamycin Is Effective against In Vitro and In Vivo Models of Human Glioblastoma
Despite numerous clinical trials, glioblastoma (GBM) remains a tumor that is difficult to treat. The aim of this study was to investigate the potential of a new pharmacological approach, combining doxorubicin (Dox) and rapamycin (Rapa), in in vitro and in vivo GBM models. Cytotoxic and anti-prolifer...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2019-03-01
|
| シリーズ: | Journal of Clinical Medicine |
| 主題: | |
| オンライン･アクセス: | http://www.mdpi.com/2077-0383/8/3/331 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|